Delivery Order SPE2DR25D3301-SPE2DR26F20NP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,010.94 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.56 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $2,383.48. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency awarded a delivery order valued at $4,154.30 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. Performance will be executed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Lyrica 150 mg capsules (90-count units) valued at $1,723.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.40 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count unit) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,279.00 to AmerisourceBergen Drug Corp for Lyrica 25 mg capsules (90-count) on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,281.51 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on September 22, 2025, with a completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lyrica (pregabalin) is a neurological treatment used primarily for...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20NPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,866.31 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules in unit dose packaging (100 count). The contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order represents a routine pharmaceutical procurement supporting federal military healthcare operations. Lyrica (pregabalin) is a commonly prescribed neurological medication used for pain management and neuropathic conditions within military treatment facilities and veterans' healthcare systems. As a major pharmaceutical distributor with established capabilities to meet federal procurement requirements, AmerisourceBergen Drug Corp fulfills essential medical supply needs across multiple therapeutic domains through its expansive contract vehicle with DLA, ensuring consistent availability of critical medications to support military medical readiness and service member health outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/11/26 |